Canada Life’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Sell
20,305
-974
-5% -$75.8K ﹤0.01% 1243
2025
Q4
$1.63M Sell
21,279
-8,352
-28% -$631K ﹤0.01% 1228
2025
Q3
$2.28M Buy
29,631
+363
+1% +$30.3K ﹤0.01% 1174
2025
Q2
$2.46M Buy
29,268
+293
+1% +$25.6K ﹤0.01% 1110
2025
Q1
$2.75M Sell
28,975
-2,231
-7% -$236K ﹤0.01% 1069
2024
Q4
$3.43M Sell
31,206
-2,065
-6% -$236K 0.01% 1020
2024
Q3
$3.75M Sell
33,271
-1,051
-3% -$122K 0.01% 1020
2024
Q2
$4.24M Buy
34,322
+4,434
+15% +$555K 0.01% 909
2024
Q1
$3.85M Buy
29,888
+1,864
+7% +$226K 0.01% 940
2023
Q4
$3.45M Buy
28,024
+434
+2% +$46.2K 0.01% 966
2023
Q3
$2.82M Buy
27,590
+161
+0.6% +$16.8K 0.01% 1014
2023
Q2
$2.75M Sell
27,429
-1,326
-5% -$133K 0.01% 1023
2023
Q1
$2.95M Sell
28,755
-1,513
-5% -$163K 0.01% 1030
2022
Q4
$3.11M Buy
30,268
+24
+0.1% +$2.44K 0.01% 997
2022
Q3
$2.59M Buy
30,244
+5,695
+23% +$538K 0.01% 1027
2022
Q2
$2.35M Buy
24,549
+3,123
+15% +$304K 0.01% 1082
2022
Q1
$2.03M Buy
21,426
+7
+0% +$663 ﹤0.01% 1191
2021
Q4
$1.93M Buy
21,419
+26
+0.1% +$2.3K ﹤0.01% 1216
2021
Q3
$1.81M Buy
21,393
+448
+2% +$40K ﹤0.01% 1240
2021
Q2
$1.9M Sell
20,945
-232
-1% -$23K ﹤0.01% 1188
2021
Q1
$2.17M Sell
21,177
-2,881
-12% -$285K 0.01% 1090
2020
Q4
$2.18M Sell
24,058
-3,441
-13% -$267K ﹤0.01% 1088
2020
Q3
$1.74M Sell
27,499
-3,075
-10% -$228K ﹤0.01% 1135
2020
Q2
$2.36M Sell
30,574
-1,783
-6% -$130K 0.01% 987
2020
Q1
$2.24M Buy
32,357
+2,317
+8% +$212K 0.01% 894
2019
Q4
$3.08M Buy
+30,040
New +$2.87M 0.01% 901
2019
Q3
Sell
-33,841
Closed -$3.08M 1685
2019
Q2
$3.08M Buy
33,841
+1,032
+3% +$87K 0.01% 939
2019
Q1
$2.73M Buy
32,809
+832
+3% +$62K 0.01% 877
2018
Q4
$1.82M Buy
31,977
+1,147
+4% +$78.9K 0.01% 1061
2018
Q3
$2.37M Sell
30,830
-1,310
-4% -$102K 0.01% 1063
2018
Q2
$2.46M Buy
32,140
+8
+0% +$600 0.01% 1039
2018
Q1
$2.21M Buy
32,132
+1,309
+4% +$91K 0.01% 1087
2017
Q4
$2.18M Sell
30,823
-1,954
-6% -$130K 0.01% 1117
2017
Q3
$2.01M Sell
32,777
-2,238
-6% -$134K 0.01% 1145
2017
Q2
$2.29M Buy
35,015
+1,020
+3% +$65.5K 0.01% 1050
2017
Q1
$2.2M Buy
33,995
+2,353
+7% +$157K 0.01% 1070
2016
Q4
$2.17M Sell
31,642
-573
-2% -$36.9K 0.01% 1041
2016
Q3
$1.96M Buy
32,215
+423
+1% +$23.5K 0.01% 1058
2016
Q2
$1.46M Buy
31,792
+29,224
+1,138% +$1.38M ﹤0.01% 1213
2016
Q1
$111K Hold
2,568
﹤0.01% 1728
2015
Q4
$139K Hold
2,568
﹤0.01% 1522
2015
Q3
$120K Hold
2,568
﹤0.01% 1579
2015
Q2
$115K Hold
2,568
﹤0.01% 1757
2015
Q1
$119K Buy
2,568
+1,510
+143% +$64.8K ﹤0.01% 1687
2014
Q4
$45K Hold
1,058
﹤0.01% 2128
2014
Q3
$38K Hold
1,058
﹤0.01% 2142
2014
Q2
$45K Hold
1,058
﹤0.01% 1991
2014
Q1
$47K Hold
1,058
﹤0.01% 1822
2013
Q4
$49K Buy
+1,058
New +$48.5K ﹤0.01% 1794

Other funds holding IOSP

Canada Life's IOSP Position: Q1 2026 in Review

Canada Life reduced its Innospec (IOSP) stake by 4.6% in Q1 2026, selling an estimated $75.8K and leaving 20,305 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Canada Life first reported a position in IOSP in Q4 2013 and has held it in 49 quarters since. The position peaked at $4.24M in Q2 2024. 266 funds tracked by Wall St. Rank hold IOSP as of Q1 2026.

  • Canada Life held 20,305 shares of Innospec worth $1.48M as of Q1 2026.
  • Canada Life sold 974 Innospec shares in Q1 2026, an estimated $75.8K.
  • Innospec made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1243 holding.
  • Canada Life first reported a position in Innospec in Q4 2013 and has held it in 49 quarters since.
  • Canada Life's Innospec position peaked at $4.24M in Q2 2024.
  • 266 funds tracked by Wall St. Rank held Innospec as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.